KINISOQUIN

Quercis Pharma AG

Application Filed: 2020-03-16

Trademark Application Details

Mark For: KINISOQUIN™ trademark registration is intended to cover the categories of pharmaceutical preparations for the treatment of thrombosis, sickle cell disease, chronic obstructive pulmonary disease, amyotrophic lateral sclerosis, pancreatic cancer, ovarian cancer, ebola virus and covid-19. [all]

Status

2022-02-24 UTC

LIVE APPLICATION Under Examination

The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.

Research	OneLook Acronym Finder
Serial Number	88836223
Mark Literal Elements	KINISOQUIN
Mark Drawing Type	4 - STANDARD CHARACTER MARK
Mark Type	TRADEMARK
Register	PRINCIPAL
Current Location	INTENT TO USE SECTION 2021-04-27
Basis	1(b)
Class Status	ACTIVE
Primary US Classes	005: Adhesives 006: Chemicals and Chemical Compositions 018: Medicines and Pharmaceutical Preparations 044: Dental, Medical and Surgical Appliances 046: Foods and Ingredients of Foods 051: Cosmetics and Toilet Preparations 052: Detergents and Soaps
Primary International Class	005 - Primary Class (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use	No
Current Use	No
Intent To Use	Yes
Filed ITU	Yes
44D Filed	No
44E Current	No
66A Current	No
Current Basis	No
No Basis	No
Attorney Name	Victoria D Summerfield

Timeline

2020-03-16	Application Filed
2020-03-19	Location: NEW APPLICATION PROCESSING
2020-03-19	Status: Live/Pending
2020-03-19	Transaction Date
2021-03-02	Published
2021-04-27	Location: INTENT TO USE SECTION
2021-10-27	Status: A first request for extension of time to file a Statement of Use has been granted.

Trademark Parties (Applicants & Owners)

Party:	Quercis Pharma AG
Address	Nordstrasse 5 Zug SWITZERLAND 6300
Legal Entity Type	Corporation
Legal Entity State	SWITZERLAND

Documents

Application		2020-03-16
Drawing		2020-03-16
Non-Final Action		2020-07-17
summary-SearchSummary202007171514374640400616		2020-07-17
summary-SearchSummary202007171529574070400396		2020-07-17
Offc Action Outgoing		2020-07-30
Response to Office Action		2021-01-20
Amendment and Mail Process Complete		2021-01-22
TRAM Snapshot of App at Pub for Oppostn		2021-01-23
Notice of Publication		2021-02-10
Notification Of Notice of Publication		2021-02-10
OG Publication Confirmation		2021-03-02
Notice of Allowance		2021-04-27
Extension of Time to File SOU		2021-10-27
ITU Extension Approval		2021-10-29
ITU Unit Action		2021-10-29

Attorney of Record

VICTORIA D SUMMERFIELD
PEPPER HAMILTON LLP
501 GRANT STREET SUITE 300
PITTSBURGH, PA 15219

Good, Services, and Codes

IC 005. US 005 006 018 044 046 051 052. G & S: PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF THROMBOSIS, SICKLE CELL DISEASE, CHRON
IC OBSTRUCTIVE PULMONARY DISEASE, AMYOTROPH
IC LATERAL SCLEROSIS, PANCREAT
IC CANCER, OVARIAN CANCER, EBOLA VIRUS AND COVID-19

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
GS0051	PHARMACEUTICAL PREPARATIONS INCLUDING THOSE FOR THE TREATMENT OF THROMBOSIS, SICKLE CELL DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, PANCREATIC CANCER, OVARIAN CANCER, EBOLA VIRUS AND COVID-19

Trademark Filing History

Description	Date	Proceeding Number
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2021-10-29
TEAS EXTENSION RECEIVED	2021-10-27
EXTENSION 1 GRANTED	2021-10-27	98765
EXTENSION 1 FILED	2021-10-27	98765
NOA E-MAILED - SOU REQUIRED FROM APPLICANT	2021-04-27
PUBLISHED FOR OPPOSITION	2021-03-02
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	2021-03-02
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	2021-02-10
APPROVED FOR PUB - PRINCIPAL REGISTER	2021-01-22
TEAS/EMAIL CORRESPONDENCE ENTERED	2021-01-21	88889
TEAS RESPONSE TO OFFICE ACTION RECEIVED	2021-01-20
CORRESPONDENCE RECEIVED IN LAW OFFICE	2021-01-20	88889
NOTIFICATION OF NON-FINAL ACTION E-MAILED	2020-07-30	6325
NON-FINAL ACTION WRITTEN	2020-07-30	85327
NON-FINAL ACTION E-MAILED	2020-07-30	6325
NOTIFICATION OF NON-FINAL ACTION E-MAILED	2020-07-17
NON-FINAL ACTION WRITTEN	2020-07-17	85327
NON-FINAL ACTION E-MAILED	2020-07-17
ASSIGNED TO EXAMINER	2020-07-15	85327
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2020-03-20
NEW APPLICATION ENTERED IN TRAM	2020-03-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.